KATELYN UHLEMANN: Open Payments
NPI 1144628223 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 29 payments from 10 companies in 2025. Trend: 2023 $617 · 2024 $469 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $237 |
| Amneal Pharmaceuticals LLC | 5 | $100 |
| ABBVIE INC. | 3 | $69 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 2 | $45 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: UNITHROID, AIRSUPRA, BREZTRI, MOUNJARO, Wegovy, QULIPTA, UBRELVY, PURIFIED CORTROPHIN GEL.
Industry payments across CO — which companies pay providers there.
